A New Option for Some People With Lung Cancer: What the Approval of Lorlatinib Means for Patients

A New Option for Some People With Lung Cancer: What the Approval of Lorlatinib Means for Patients

The FDA recently approved the drug lorlatinib for the treatment of some non-small cell lung cancer. Doctors talk to SurvivorNet about the significance of this approval.

NOW
PLAYING
FDA Approves Combination of Keytruda & Lenvima For Treatment Of Advanced Uterine Cancer: What Women Need To Know
NOW
PLAYING
Lung Cancer Patients Who Quit Smoking Live Longer
NOW
PLAYING
Pfizer Issues New Nationwide Recall of Anti-Smoking Drug Chantix
NOW
PLAYING
Oncologists Support COVID-19 Booster Shot, Masks For Cancer Patients
NOW
PLAYING
Cancer Care Cost $209 Billion in 2020, While Cancer Drug Prices Nearly Doubled In the Last Decade
NOW
PLAYING
87% of Eligible Patients Skip Lung Cancer Screening, Analysis Finds

SurvivorNetTV.
Hope. Science.
Inspiration.

WATCH NOW
×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.